According to information shared by the World Health Organisation (WHO) and French health authorities, as reported by Reuters, investigations are underway to establish how the man contracted the virus, identify the possible source of exposure and determine whether the infection has any broader public health implications.
The development has drawn attention to a pathogen whose effects on humans remain largely unknown, with no other human infections documented so far.
The WHO is working with French authorities to investigate the circumstances surrounding the case, including the possible route of transmission. However, the discovery of a single human infection does not, in itself, establish that the virus is spreading among people or poses a widespread public health threat.
Previously identified in animals, the Shamonda virus has been associated primarily with livestock infections. Its potential effects on humans, including the symptoms it may cause and the severity of illness, remain insufficiently understood.
What is the Shamonda virus?
The Shamonda virus was first identified in cattle in Nigeria in the 1960s. It belongs to the Orthobunyavirus group, a broad classification of viruses that includes pathogens affecting both animals and humans.
Since its discovery, the virus has been detected intermittently in animals in parts of Africa and Asia. Its known hosts include cattle, sheep, goats and horses, with reports also involving alpacas.
The virus is believed to be transmitted among animals through the bites of infected Culicoides midges, small, blood-feeding insects that serve as vectors.
Shamonda virus belongs to the same broader viral group as the Schmallenberg virus, which is known to cause reproductive complications in livestock.
In animals, reported signs of infection include fever, diarrhoea, reduced appetite and decreased milk production. In more serious cases, infection may be associated with reproductive problems, including abortions, stillbirths and congenital abnormalities in newborn animals.
However, these symptoms are documented in animals and should not be assumed to represent the clinical effects of the virus in humans.
How does the virus spread?
Infected Culicoides midges are considered the principal vectors of the Shamonda virus. The insects can acquire the pathogen while feeding on infected animals and subsequently transmit it to other susceptible animals.
According to the information provided about the French case, the patient lived in an area where the virus had been detected in animals and where Culicoides midges were present.
Nevertheless, the precise circumstances of his infection have not been established. Investigators are working to determine whether exposure occurred through an infected insect or another route.
At present, there is no established evidence that Shamonda virus spreads from one person to another. There is also no confirmed evidence that simply touching, handling or being near infected livestock transmits the virus to humans.
The WHO has indicated that further research is needed to clarify the pathogen's transmission pathways and establish how the reported human infection occurred.
What are the symptoms in humans?
The symptoms of Shamonda virus infection in humans remain unknown because this is the first known human case reported.
Consequently, there is not yet enough clinical evidence to establish a reliable list of human symptoms, determine the typical course of illness or assess the likelihood of severe complications.
Although the virus has been associated with fever, diarrhoea, reduced appetite and reproductive complications in livestock, these findings cannot automatically be applied to human infections.
The reported death has raised questions about the potential severity of the infection, particularly in people with weakened immune systems. However, a single case involving an immunocompromised patient is insufficient to determine how the virus affects the wider population or whether immune suppression contributed to the outcome.
Further clinical and epidemiological investigations will be necessary to establish the disease's characteristics in humans.
Does the virus pose a public health risk?
The identification of the first known human case warrants scientific investigation and continued monitoring, but it does not automatically indicate an emerging epidemic or widespread threat to public health.
The WHO and French authorities are seeking to establish the source of the infection, determine the likely route of transmission and assess whether additional cases or other potential public health concerns exist.
The absence of documented human-to-human transmission is an important distinction in evaluating the current situation. However, because human infections have not been sufficiently studied, the possibility of other transmission routes cannot be conclusively assessed at this stage.
The investigation is therefore expected to provide important information about the virus's ability to infect humans, the circumstances that may facilitate transmission and the potential risks to vulnerable individuals.
For now, the available information remains limited, and further findings will be needed to determine the significance of the case.
The emergence of a previously animal-associated pathogen in a human highlights the importance of cooperation between human and animal health authorities, particularly in monitoring infectious diseases that circulate in livestock and the insects that transmit them.
As investigations continue, researchers and public health officials will need to establish whether the French case represents an isolated infection or points to a previously unrecognised risk to human health.